Relationship between tumor size and survival in non-small cell lung cancer (NSCLC): An analysis of the Surveillance, Epidemiology, and End Results (SEER) registry.

被引：0
|
作者：
Zhang, Jianjun [1 ]
Gold, Kathryn A. [1 ]
Lin, Heather [1 ]
Swisher, Stephen [1 ]
Lippman, Scott Michael [1 ]
Lee, J. Jack [1 ]
Kim, Edward S. [1 ]
William, William [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7047
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Utility of surveillance imaging in stage III non-small cell lung cancer (NSCLC) patients: A SEER-Medicare analysis
    Thakur, Manish K.
    Ruterbusch, Julie
    Schwartz, Ann G.
    Beebe-Dimmer, Jennifer Lynn
    Holowatyj, Andreana N.
    Wozniak, Antoinette J.
    Gadgeel, Shirish M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [42] Relationship of tumor size to survival in patients with pN0 non-small cell lung cancer
    Uchiyama, Mika
    Kawaguchi, Koji
    Okasaka, Toshiki
    Ito, Shimon
    Sato, Naohito
    Taniguchi, Tetsuo
    Usami, Noriyasu
    Yokoi, Kohei
    CHEST, 2006, 130 (04) : 231S - 232S
  • [43] SECONDARY PRIMARY TUMOR AND SURVIVAL OUTCOME IN MEDULLOBLASTOMA: A SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) ANALYSIS
    Nantavithya, Chonnipa
    Yeboa, Debra
    Liao, Kaiping
    McGovern, Susan
    Grosshans, David
    McAleer, Mary
    Woodhouse, Kristina
    Khatua, Soumen
    Chintagumpala, Murali
    Paulino, Arnold
    NEURO-ONCOLOGY, 2018, 20 : 125 - 125
  • [44] Risk of cardiac-related mortality in stage IIIA-N2 non-small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database
    Sun, Xin
    Men, Yu
    Wang, Jianyang
    Bao, Yongxing
    Yang, Xu
    Zhao, Maoyuan
    Sun, Shuang
    Yuan, Meng
    Ma, Zeliang
    Hui, Zhouguang
    THORACIC CANCER, 2021, 12 (09) : 1358 - 1365
  • [45] EPIDEMIOLOGY AND COSTS OF NON-SMALL CELL LUNG CANCER (NSCLC) IN AUSTRIA
    Walter, E.
    Hausberger, S.
    Lazic-Peric, A.
    VALUE IN HEALTH, 2018, 21 : S34 - S34
  • [46] Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): evidence from the surveillance, epidemiology, and end results (SEER) program and the national lung screening trial (NLST)
    Goldwasser, Deborah L.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (06) : 1280 - 1292
  • [47] Surgical modality for stage IA non-small cell lung cancer among the elderly: analysis of the Surveillance, Epidemiology, and End Results database
    Wang, Weixi
    Sun, Yan
    Li, Huiting
    Bao, Minwei
    Liu, Xiaogang
    Jiang, Gening
    Ye, Cong
    Hu, Yu
    JOURNAL OF THORACIC DISEASE, 2020, 12 (11) : 6731 - 6742
  • [48] Risk of cardiac (CD) and pulmonary (PD) death after post-operative radiotherapy (PORT) for non-small cell lung cancer (NSCLC): Analysis of the Surveillance, Epidemiology, and End-Results (SEER) program.
    Lally, B. E.
    Detterbeck, F. C.
    Thomas, C. R., Jr.
    Machtay, M.
    Miller, A. A.
    Oaks, T. E.
    Petty, W. J.
    Robbins, M. E.
    Blackstock, A. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 331S - 331S
  • [49] CHARACTERIZATION OF THE RELATIONSHIP BETWEEN IPILIMUMAB EXPOSURE, TUMOR SIZE, AND SURVIVAL IN PREVIOUSLY UNTREATED NON-SMALL CELL LUNG CANCER PATIENTS
    Feng, Y.
    Masson, E.
    Williams, D.
    Song, J.
    Cuillerot, J.
    Roy, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S32 - S32
  • [50] Influence Of Demographic Factors On Five Year Survival In Non-Small Cell Lung Cancer (nsclc): A Seer Study
    Kanitkar, A. A.
    Schwartz, A.
    Soubani, A.
    Joshi, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
12345